Correlation of Released HMGB1 Levels with the Degree of Islet Damage in Mice and Humans and with the Outcomes of Islet Transplantation in Mice
- 1 July 2012
- journal article
- research article
- Published by SAGE Publications in Cell Transplantation
- Vol. 21 (7) , 1371-1381
Abstract
Establishing reliable islet potency assay is a critical and unmet issue for clinical islet transplantation. Recently, we reported that islets contained high levels of high mobility group box 1 (HMGB1) and damaged islets released HMGB1 in a mouse model. In this study, we hypothesized that the amount of released HMGB1 could reflect the degree of islet damage, and could predict the outcome of islet transplantation. Four groups of damaged mouse islets and three groups of damaged human islets were generated by hypoxic conditions. These islets were assessed by in vivo (transplantation) and in vitro (released HMGB1 levels, released C-peptide levels, PI staining, TUNEL staining, ATP/DNA, and glucose-stimulated insulin release test) assays. In addition, the ability of each assay to distinguish between noncured ( n = 13) and cured ( n = 7) mice was assessed. The curative rates of STZ-diabetic mice after receiving control, hypoxia-3h, hypoxia-6h, and hypoxia-24h mouse islets were 100%, 40%, 0%, and 0%, respectively. Only amounts of released HMGB1 and ratio of PI staining significant increased according to the degree of damages in both human and mouse islets. In terms of predictability of curing diabetic mice, amounts of released HMGB1 showed the best sensitivity (100%), specificity (100%), positive (100%), and negative predictive values (100%) among all the assays. The amount of released HMGB1 reflected the degree of islet damage and correlated with the outcome of islet transplantation in mice. Hence, released HMGB1 levels from islets should be a useful marker to evaluate the potency of isolated islets.Keywords
This publication has 35 references indexed in Scilit:
- High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in miceJournal of Clinical Investigation, 2010
- Seven Consecutive Successful Clinical Islet Isolations with Pancreatic Ductal InjectionCell Transplantation, 2010
- Islet cell transplantation for Type 1 diabetesJournal of Diabetes, 2010
- Islet assessment for transplantationCurrent Opinion in Organ Transplantation, 2009
- Efficacy Comparison Between Intraportal and Subcapsular Islet Transplants in a Murine Diabetic ModelTransplantation Proceedings, 2009
- Acute Antibody-Mediated Complement Activation Mediates Lysis of Pancreatic Islets Cells and May Cause Tissue Loss in Clinical Islet TransplantationTransplantation, 2008
- The ATP/DNA Ratio Is a Better Indicator of Islet Cell Viability Than the ADP/ATP RatioTransplantation Proceedings, 2008
- Human Islet Oxygen Consumption Rate and DNA Measurements Predict Diabetes Reversal in Nude MiceAmerican Journal of Transplantation, 2007
- Quantification of Basal and Stimulated ROS Levels as Predictors of Islet Potency and FunctionAmerican Journal of Transplantation, 2006
- Effect of the two-layer (University of Wisconsin solution???perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol1Transplantation, 2002